NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

醫院感染:設備、藥物和環境產品

Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products

出版商 BCC Research 商品編碼 1014812
出版日期 內容資訊 英文 213 Pages
訂單完成後即時交付
價格
醫院感染:設備、藥物和環境產品 Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products
出版日期: 2021年06月17日內容資訊: 英文 213 Pages
簡介

2021 年至 2026 年,全球醫院感染市場預計將以 8.6% 的複合年增長率增長,從 2021 年的 240 億美元增長到 2026 年的 362 億美元。據預測。

此外,市場上環境殺菌細分市場的複合年增長率為8.8%,醫療器械細分市場的複合年增長率為8.6%,預計2021年至2026年將繼續增長。

本報告調查了全球醫院感染市場,包括市場規模、預測、趨勢、增長和抑制因素、機會和專利、競爭條件、按技術類型/用途/地區劃分的市場份額以及主要公司。提供的信息包括個人資料。

目錄

第 1 章介紹

  • 調查目的和目的
  • 進行本次調查的原因
  • 報告範圍
  • 來源
  • 調查方法
  • 地域細分
  • 分析師生涯
  • BCC 自定義調查
  • 相關 BCC 調查報告

第 2 章總結和亮點

第 3 章概述

  • 醫療傳染病
  • 傳染病的種類
  • 中心靜脈導管相關血流
  • 手術部位感染
  • 導管相關尿路感染
  • 呼吸機相關肺炎
  • 衛生保健環境中的疾病和傳染性病原體
  • 不動桿菌
  • 伯克霍爾德菌
  • 艱難梭菌
  • 梭菌焊接
  • 腸桿菌科(耐碳青黴烯類)
  • 革蘭氏陰性菌
  • 肝炎
  • 艾滋病毒/艾滋病
  • 流感
  • 克雷伯氏菌
  • 耐甲氧西林金黃色葡萄球菌
  • 膿腫分枝桿菌
  • 諾如病毒
  • 銅綠假單胞菌
  • 金黃色葡萄球菌
  • 耐萬古黴素腸球菌
  • 發生率和流行率
  • 風險因素
  • 預防策略
  • 基本感染預防和管理
  • 抗生素和多重耐藥菌
  • 設備相關感染控制
  • 治療相關指南
  • 制定具體指導方針
  • 世衛組織指南
  • 監控系統

第 4 章市場概述與分析

  • 全球感染控制市場
  • 區域分析
  • 市場增長因素
  • 抗菌劑抗性
  • 人口增長和人口變化
  • 新興市場
  • 新科技
  • 接種率
  • 越來越關注 HCAI
  • 市場限制
  • 新方法的成本效益
  • 未滿足的需求
  • 有效處理 "超級bug"

第 5 章醫藥品

  • HCAI 醫藥市場
  • 抗生素
  • 作用機制
  • 抗生素耐藥性
  • 抗生素耐藥機制
  • 抗生素耐藥性的原因
  • 抗菌素耐藥性(抗生素):發生率
  • 抗生素耐藥性:醫院和醫療機構
  • 抗擊抗菌素耐藥性的達沃斯宣言
  • 細菌性HCAI抗生素
  • 市售抗生素
  • 全球抗生素市場
  • 抗真菌藥
  • HCAI抗真菌劑
  • 市售抗真菌劑
  • 抗真菌劑的全球市場
  • 抗病毒藥物和疫苗
  • 乙型肝炎和丙型肝炎
  • 流感

第 6 章環境處理

  • HCAI:環境治理市場
  • 消毒劑
  • 類型
  • 主要商業醫院消毒劑
  • 患者皮膚護理
  • 用於患者皮膚治療的主要商用消毒劑
  • 患者皮膚治療市場
  • 環境殺菌
  • 空氣處理
  • 房間過濾系統
  • 房間加壓
  • 紫外線消毒
  • 水處理
  • 設備/設施消毒
  • 加熱殺菌
  • 化學殺菌
  • 輻射滅菌
  • 環保殺菌市場

第 7 章醫療器械

  • HCAI 醫療器械市場
  • 抗菌塗層
  • 導管
  • 患者通氣系統
  • 類型
  • 治療和設備
  • IV 過濾器
  • IV 過濾器市場

第 8 章產業結構

  • 衛生保健感染預防產業結構
  • 供應商
  • 客戶
  • 消費者

第 9 章調查和機會

  • 新科技
  • 手衛生
  • 患者追蹤
  • 自消毒表面
  • 自動去污技術
  • 智能係統和預測分析
  • 其他技術
  • 抗生素管道
  • 病毒感染管道:乙型肝炎治療
  • 病毒感染流感治療管道
  • 真菌感染治療管道

第 10 章專利/專利申請分析

  • 製藥
  • 抗生素
  • 乙型肝炎的治療
  • 丙型肝炎的治療
  • 流感治療
  • 抗真菌治療
  • 環境殺菌
  • 消毒劑
  • 患者皮膚的預備治療
  • 空氣處理技術
  • 水處理技術
  • 醫療設備
  • 導管和氣管插管
  • IV 過濾器(內聯)

第 11 章公司簡介

  • Pharmaceutical Companies
  • GILEAD SCIENCES
  • MERCK
  • NOVARTIS
  • PFIZER
  • ROCHE
  • SANOFI PASTEUR
  • SEQIRUS
  • Companies in Sterilization/Disinfection Industry
  • 3M HEALTHCARE
  • ADVANCED STERILIZATION PRODUCTS
  • BECTON, DICKINSON AND COMPANY
  • BELIMED
  • THE CLOROX COMPANY
  • STERIGENICS
  • XENEX DISINFECTION SERVICES
  • Medical Device Companies
  • BACTIGUARD
  • TELEFLEX

第 12 章附錄

目錄
Product Code: HLC092E

Highlights:

The global market HCAI Control should grow from $24.0 billion in 2021 to $36.2 billion by 2026, at compound annual growth rate (CAGR) of 8.6% for the period of 2021-2026.

Environment sterilization as a segment of HCAI Control should grow from $12.0 billion in 2021 to $18.3 billion by 2026, at a CAGR of 8.8% for the period of 2021-2026.

Medical devices as a segment of HCAI Control should grow from $5.5 billion in 2021 to $36.2 billion by 2025, at a CAGR of 8.6% for the period of 2021-2026.

Report Scope

The report focuses on select drugs (antimicrobials), environment treatment (disinfectants, sterilization systems etc.) and provisions in medical devices (e.g., catheters, patient ventilation devices, sterile IV filters) that prevent the occurrence of nosocomial infections.

Within each type of treatment, regional analyses will focus on the Americas (i.e., Canada, the U.S., Mexico, Central America and South America), EMRA (i.e., Europe, the Middle East, Russia and Africa) and Asia-Pacific (i.e., Japan, China, India, other Western Pacific countries such as Australia and New Zealand, and other Southeast Asian countries).

Report Includes

  • 72 tables
  • An updated review of the global healthcare-acquired infection (HCAI)-control market
  • Analyses of the global market trends, with data from 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
  • Highlights of select antimicrobials drugs and environment sterilization/disinfection products currently used or under development for treatment of healthcare-associated infections
  • Market outlook and forecast trends of pharmaceutical treatment (antimicrobials and vaccines), environment treatment (disinfectants, sterilization systems etc.) and provisions in medical devices (catheters, patient ventilation devices, sterile intravenous [IV] filters) that prevent the occurrence of nosocomial infections
  • Estimation of the market size and revenue forecasts for HCAI-control market, and corresponding market share analysis by key market segments - technology type, application, and geography
  • Discussion of the key market dynamics, industry structure, regulatory approval, market deterrents, unmet needs and other factors driving opportunities in microbiology research
  • A look at the pipeline products for antimicrobial resistance (AMR), hospital surveillance methods and tools used to control HCAI infections
  • Review of the U.S. patent grants for innovations in infectious diseases control and viral infections
  • Profile descriptions of the leading industry players including 3M, Merck, Novartis', Pfizer, Roche, and Sanofi

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Overview

  • Healthcare-Acquired Infections
  • Types of Infections
  • Central-Line-Associated Bloodstream Infections
  • Surgical Site Infections
  • Catheter-Associated Urinary Tract Infections
  • Ventilator-Associated Pneumonia
  • Diseases and Infectious Agents in Healthcare Settings
  • Acinetobacter
  • Burkholderia Cepacia
  • Clostridium Difficile
  • Clostridium Sordellii
  • Enterobacteriaceae (Carbapenem-Resistant)
  • Gram-Negative Bacteria
  • Hepatitis
  • HIV/AIDS
  • Influenza
  • Klebsiella
  • Methicillin-Resistant Staphylococcus aureus
  • Mycobacterium Abscessus
  • Norovirus
  • Pseudomonas Aeruginosa
  • Staphylococcus Aureus
  • Vancomycin-Resistant Enterococci
  • Incidence and Prevalence
  • Risk Factors
  • Prevention Strategies
  • Basic Infection Prevention and Control
  • Antibiotics and Multidrug-Resistant Organisms
  • Device-Associated Infection Control
  • Procedure-Associated Guidelines
  • Setting Specific Guidelines
  • WHO Guidelines
  • Surveillance Systems

Chapter 4 Market Summary and Analysis

  • Global Market for Infection Control
  • Regional Analysis
  • Market Drivers
  • Antimicrobial Resistance
  • Increasing Population and Demographic Changes
  • Emerging Markets
  • New Technologies
  • Vaccine Coverage
  • Increase in Focus on HCAIs
  • Market Deterrents
  • Cost-Effectiveness of Newer Methods
  • Unmet Needs
  • Effective Treatment for "Superbugs"

Chapter 5 Pharmaceuticals

  • HCAI Pharmaceutical Market
  • Antibiotics
  • Mechanism of Action
  • Antibiotic Resistance
  • Mechanisms of Antibiotic Resistance
  • Reasons for Antibiotic Resistance
  • Antimicrobial Resistance (Antibiotics): Incidence
  • Antibiotic Resistance: Hospitals and Healthcare Settings
  • Davos Declaration for Combating Antimicrobial Resistance
  • Antibiotics for Bacterial HCAIs
  • Select Marketed Antibiotics
  • Global Market for Antibiotics
  • Antifungal Drugs
  • Antifungals for HCAI
  • Select Marketed Antifungals
  • Global Market for Antifungals
  • Antivirals and Vaccines
  • Hepatitis B and Hepatitis C
  • Influenza

Chapter 6 Environmental Treatment

  • HCAI: Environmental Treatment Market
  • Disinfectants
  • Types
  • Key Marketed Hospital-Use Disinfectants
  • Patient Skin Preparation
  • Key Marketed Patient Skin Preparation Antiseptics
  • Patient Skin Preparation Market
  • Environment Sterilization
  • Air Treatment
  • Room Filtration Systems
  • Room Pressurization
  • UV Light Disinfection
  • Water Treatment
  • Equipment/Facility Sterilization
  • Heat Sterilization
  • Chemical Sterilization
  • Radiation-Based Sterilization
  • Environment Sterilization Market

Chapter 7 Medical Devices

  • HCAI Medical Device Market
  • Antimicrobial Coatings
  • Catheters
  • Patient Ventilation Devices
  • Types
  • Treatments and Devices
  • IV Filters
  • IV Filter Market

Chapter 8 Industry Structure

  • Industry Structure for Healthcare Infection Prevention
  • Suppliers
  • Customers
  • Consumers

Chapter 9 Research and Opportunities

  • New Technologies
  • Hand Hygiene
  • Patient Tracing
  • Self-Disinfecting Surfaces
  • Automated Decontamination Technologies
  • Smart Systems and Predictive Analytics
  • Other Technologies
  • Antibiotics Pipeline
  • Viral Infection Pipeline: Hepatitis B Treatments
  • Pipeline of Viral Infection Influenza Treatments
  • Fungal Infection Treatment Pipeline

Chapter 10 Patent/Patent Application Analysis

  • Pharmaceuticals
  • Antibiotics
  • Hepatitis B Treatments
  • Hepatitis C Treatments
  • Influenza Treatments
  • Antifungal Treatments
  • Environment Sterilization
  • Disinfectants
  • Patient Skin Preparation Treatments
  • Air Treatment Technologies
  • Water Treatment Technologies
  • Medical Devices
  • Catheters and Endotracheal Tubes
  • IV Filters (In-Line)

Chapter 11 Company Profiles

  • Pharmaceutical Companies
  • GILEAD SCIENCES
  • MERCK
  • NOVARTIS
  • PFIZER
  • ROCHE
  • SANOFI PASTEUR
  • SEQIRUS
  • Companies in Sterilization/Disinfection Industry
  • 3M HEALTHCARE
  • ADVANCED STERILIZATION PRODUCTS
  • BECTON, DICKINSON AND COMPANY
  • BELIMED
  • THE CLOROX COMPANY
  • STERIGENICS
  • XENEX DISINFECTION SERVICES
  • Medical Device Companies
  • BACTIGUARD
  • TELEFLEX

Chapter 12 Appendix

List of Tables

  • Summary Table B : Global Market for HCAI Control, by Region, Through 2026
  • Summary Table A : Global Market for HCAI Control, by Segment, Through 2026
  • Table 1 : Pooled Cumulative Incidence of HCAI and Device-Associated Infections in Adults, 1995-2010
  • Table 2 : HCAIs, LTACHs and IRFs in the U.S., 2019
  • Table 3 : SSI Rates for Select Procedures, U.S., 2019
  • Table 4 : Sterilization and Disinfection Methods, CDC Guidelines, Updated February 2017
  • Table 5 : Air-Handling Systems in Healthcare, CDC Recommendations, Updated February 2017
  • Table 6 : Controlling Spread of Waterborne Infections, CDC Recommendations, Updated February 2017
  • Table 7 : Routine Prevention of Waterborne Microbial Contamination within the Distribution System, CDC Recommendations, Updated February 2017
  • Table 8 : Proportion of Resistant Strains, by WHO Region
  • Table 9 : WHO Priority List, Pathogens for R&D of New Antibiotics
  • Table 10 : Administrative Measures, MDROs, CDC Recommendations, Updated 2006
  • Table 11 : Education and Training, MDROs, CDC Recommendations, Updated 2006
  • Table 12 : Judicious Use of Antimicrobial Agents, MDROs, CDC Recommendations, Updated 2006
  • Table 13 : Surveillance, MDROs, CDC Recommendations, Updated 2006
  • Table 14 : Appropriate Urinary Catheter Use, CDC Recommendations, Updated 2009
  • Table 15 : Urinary Catheter Maintenance, CDC Recommendations, Updated 2009
  • Table 16 : Summary of Recommendations, CRBSI, CDC, Updated 2011
  • Table 17 : SSI, CDC Recommendations, Updated 2017
  • Table 18 : Dialysis, CDC Recommendations, Updated 2016
  • Table 19 : Core Components of IPC Programs at the National and Acute Healthcare Facility Level, HCAIs, WHO Recommendations, Updated 2016
  • Table 20 : Surveillance Elements and Methodology, CDC, Updated 2006
  • Table 21 : Global Market for HCAI Control, by Segment, Through 2026
  • Table 22 : Global Market for HCAI Control, by Region, Through 2026
  • Table 23 : Global Market for HCAI Pharmaceuticals, by Category, Through 2026
  • Table 24 : Proportion of Resistant Strains, by WHO Region
  • Table 25 : WHO Priority List, Pathogens for R&D of New Antibiotics
  • Table 26 : Select Branded Antibiotics, by Manufacturer
  • Table 27 : Global Market for HCAI Antibiotics, by Class (ATC Code), Through 2026
  • Table 28 : Global Market for HCAI Antibiotics, by Region, Through 2026
  • Table 29 : Select Branded Antifungals, by Manufacturer
  • Table 30 : Global Market for HCAI Antifungals, by Class, Through 2026
  • Table 31 : Global Market for HCAI Antifungals, by Region, Through 2026
  • Table 32 : Key Marketed Hepatitis B Drugs
  • Table 33 : Global Market for Hepatitis B Therapeutics for HCAIs, by Region, Through 2026
  • Table 34 : Global Market for Hepatitis B Vaccines for HCAIs, by Region, Through 2026
  • Table 35 : Key Marketed Hepatitis C Drugs
  • Table 36 : Global Market for Hepatitis C Therapeutics for HCAIs, by Region, Through 2026
  • Table 37 : Key Marketed Influenza Vaccines
  • Table 38 : Key Marketed Antivirals for Influenza
  • Table 39 : Global Market for Influenza Vaccines for HCAIs, by Region, Through 2026
  • Table 40 : Global Market for HCAI Environment Treatment, by Category, Through 2026
  • Table 41 : Select Branded Disinfectants, by Manufacturer
  • Table 42 : Global Market for Disinfectant in Hospitals, by Region, Through 2026
  • Table 43 : Select Branded Skin Antiseptics (Preoperative Care), by Manufacturer
  • Table 44 : Global Market for Presurgical Skin Preparation, by Region, Through 2026
  • Table 45 : Global Market for Air-Filtration in Hospitals, by Region, Through 2026
  • Table 46 : Global Market for High-Temperature Sterilization, by Region, Through 2026
  • Table 47 : Global Market for Low-Temperature Sterilization, by Category, Through 2026
  • Table 48 : Global Market for Low-Temperature Sterilization, by Region, Through 2026
  • Table 49 : Global Market for Radiation-Based Sterilization, by Category, Through 2026
  • Table 50 : Global Market for Radiation-Based Sterilization, by Region, Through 2026
  • Table 51 : Global Market for HCAI Medical Devices, by Category, Through 2026
  • Table 52 : Global Market for Coated Catheters, by Category, Through 2026
  • Table 53 : Global Market for Coated Catheters, by Region, Through 2026
  • Table 54 : Global Market for Coated Endotracheal Tube, by Region, Through 2026
  • Table 55 : Global Market for IV Filters by Region, Through 2026
  • Table 56 : Global Antibiotics Development Pipeline
  • Table 57 : Hepatitis B and Hepatitis C Clinical Pipeline
  • Table 58 : Influenza A and Influenza B Clinical Pipeline
  • Table 59 : Antifungal Clinical Pipeline
  • Table 60 : Number of Patents/Patent Applications on Antibiotics, 2014-2019
  • Table 61 : Number of Patents/Patent Applications on Hepatitis B Treatments, 2014-2019
  • Table 62 : Number of Patents/Patent Applications on Hepatitis C Treatments, 2014-2019
  • Table 63 : Number of Patents/Patent Applications on Influenza Treatments, 2014-2019
  • Table 64 : Number of Patents/Patent Applications on Antifungal Treatments, 2014-2019
  • Table 65 : Number of Patents/Patent Applications on Disinfectants, 2014-2019
  • Table 66 : Number of Patents/Patent Applications on Patient Skin Preparation Treatments, 2014-2019
  • Table 67 : Number of Patents/Patent Applications on Air Treatment, 2014-2019
  • Table 68 : Number of Patents/Patent Applications on Water Treatment, 2014-2019
  • Table 69 : Number of Patents/Patent Applications on Catheters and ETTs, 2014-2019
  • Table 70 : Acronyms Used in This Report
  • Table 71 : Glossary of Terms Used in Global Markets for Infectious Diseases
  • Table 72 : Report Sources

List of Figures

  • Summary Figure A : Global Market for HCAI Control, by Segment, 2020-2026
  • Summary Figure B : Global Market for HCAI Control, by Region, 2020-2026
  • Figure 1 : Antibiotic Use* by Class, Select Classes, 2010 and 2015
  • Figure 2 : Global Market for HCAI Control, by Segment, 2020-2026
  • Figure 3 : Global Market for HCAI Control, by Region, 2020-2026
  • Figure 4 : Global Market for HCAI Pharmaceuticals, by Category, 2020-2026
  • Figure 5 : Antibiotic Use* by Class, Select Classes, 2000 and 2010
  • Figure 6 : Global Market for HCAI Antibiotics, by Class (ATC Code), 2020-2026
  • Figure 7 : Global Market for HCAI Antibiotics, by Region, 2020-2026
  • Figure 8 : Global Market for HCAI Antifungals, by Class, 2020-2026
  • Figure 9 : Global Market for HCAI Antifungals, by Region, 2020-2026
  • Figure 10 : Global Market for Hepatitis B Therapeutics for HCAIs by Region, 2020-2026
  • Figure 11 : Global Market for Hepatitis B Vaccines for HCAIs, by Region, 2020-2026
  • Figure 12 : Global Market for Hepatitis C Therapeutics for HCAIs, by Region, 2020-2026
  • Figure 13 : Global Market for Influenza Vaccines for HCAIs, by Region, 2020-2026
  • Figure 14 : Global Market for HCAI Environment Treatment, by Category, 2020-2026
  • Figure 15 : Global Market for Disinfectant Use in Hospitals, by Region, 2020-2026
  • Figure 16 : Global Market for Presurgical Skin Preparation, by Region, 2020-2026
  • Figure 17 : Global Market for Air-Filtration inHospitals, by Region, 2020-2026
  • Figure 18 : Global Market for Air-Filtration inHospitals, by Region, 2020-2026
  • Figure 19 : Global Market for Low-Temperature Sterilization, by Category, 2020-2026
  • Figure 20 : Global Market for Low-Temperature Sterilization, by Region, 2020-2026
  • Figure 21 : Global Market for Radiation-Based Sterilization, by Category, 2020-2026
  • Figure 22 : Global Market for Radiation-Based Sterilization, by Region, 2020-2026
  • Figure 23 : Global Market for HCAI Medical Devices, by Category, 2020-2026
  • Figure 24 : Global Market for Coated Catheters, by Category, 2020-2026
  • Figure 25 : Global Market for Coated Catheters, by Region, 2020-2026
  • Figure 26 : Global Market for Coated Endotracheal Tube, by Region, 2020-2026
  • Figure 27 : Global Market for IV Filters, by Region, 2020-2026
  • Figure 28 : HCAI-Prevention Industry Structure